FRM
CLBT icon

Fox Run Management’s Cellebrite CLBT Stock Holding History

Fox Run Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,470
Closed -$363K – 980
2026
Q1 		$363K Sell
27,470
-43,272
-61% -$652K 0.06% 570
2025
Q4 		$1.28M Buy
70,742
+52,756
+293% +$947K 0.2% 125
2025
Q3 		$333K Sell
17,986
-12,373
-41% -$194K 0.05% 645
2025
Q2 		$486K Buy
30,359
+1,127
+4% +$20.1K 0.08% 479
2025
Q1 		$568K Sell
29,232
-5,102
-15% -$107K 0.09% 430
2024
Q4 		$756K Buy
34,334
+2,598
+8% +$50K 0.14% 275
2024
Q3 		$534K Buy
31,736
+8,297
+35% +$123K 0.12% 326
2024
Q2 		$280K Buy
+23,439
New +$262K 0.05% 570

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Fox Run Management's CLBT Position: Q2 2026 in Review

Fox Run Management sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 27,470 shares — an estimated $363K sold.

Fox Run Management first reported a position in CLBT in Q2 2024 and held it in 8 quarters. The position peaked at $1.28M in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Fox Run Management reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 27,470 Cellebrite shares in Q2 2026, an estimated $363K.
  • Fox Run Management first reported a position in Cellebrite in Q2 2024 and held it in 8 quarters.
  • Fox Run Management's Cellebrite position peaked at $1.28M in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.